Enter your terms above and click the 'Search' button.

Showing articles 0 to 11 of 11 Filter Applied: patent foramen ovale,surgical treatment of (Click to remove) Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention Neurol 94:876-885, Messe, S.R.,et al, 2020 Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke? BMJ 362:k2515, Kuijpers, T.,et al, 2018 Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017 Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017 Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017 Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013 Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism NEJM 368:1083-1091,1152, Meier, B.,et al, 2013 Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention Stroke 43:422-431, Kitsios,G.D.,et al, 2012 Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012 Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007 Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004 Showing articles 0 to 11 of 11